NO903510L - Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. - Google Patents

Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.

Info

Publication number
NO903510L
NO903510L NO90903510A NO903510A NO903510L NO 903510 L NO903510 L NO 903510L NO 90903510 A NO90903510 A NO 90903510A NO 903510 A NO903510 A NO 903510A NO 903510 L NO903510 L NO 903510L
Authority
NO
Norway
Prior art keywords
ylcarbonyl
azaspiro
oxa
oxo
alkyl
Prior art date
Application number
NO90903510A
Other languages
English (en)
Norwegian (no)
Other versions
NO903510D0 (no
Inventor
Edit Toth
Jozsef Toerley
Bela Hegedues
Laszlo Szporny
Bela Kiss
Eva Palosi
Dora Groo
Istvan Laszlovszky
Erzsebet Lapis
Ferenc Auth
Laszlo Gaal
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO903510D0 publication Critical patent/NO903510D0/no
Publication of NO903510L publication Critical patent/NO903510L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO90903510A 1989-08-10 1990-08-09 Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. NO903510L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894092A HU204054B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same

Publications (2)

Publication Number Publication Date
NO903510D0 NO903510D0 (no) 1990-08-09
NO903510L true NO903510L (no) 1991-02-11

Family

ID=10966859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903510A NO903510L (no) 1989-08-10 1990-08-09 Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.

Country Status (22)

Country Link
US (1) US5157038A (de)
EP (1) EP0412820B1 (de)
JP (1) JPH0377886A (de)
KR (1) KR940002828B1 (de)
CN (2) CN1028531C (de)
AT (1) ATE102204T1 (de)
AU (1) AU621239B2 (de)
DD (1) DD299430A5 (de)
DE (1) DE69006973T2 (de)
DK (1) DK0412820T3 (de)
ES (1) ES2062386T3 (de)
FI (1) FI903973A7 (de)
HU (1) HU204054B (de)
IE (1) IE62297B1 (de)
IL (1) IL95322A (de)
IS (1) IS1578B (de)
MY (1) MY107125A (de)
NO (1) NO903510L (de)
NZ (1) NZ234844A (de)
PL (2) PL164654B1 (de)
YU (1) YU47749B (de)
ZA (1) ZA906298B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
EP1716156A2 (de) * 2004-02-10 2006-11-02 F.Hoffmann-La Roche Ag Modulatoren des chemokin-ccr5-rezeptors
JP2010517966A (ja) * 2007-02-01 2010-05-27 グラクソ グループ リミテッド 摂食障害の処置のための1−オキサ−3−アザスピロ(4.5)デカン−2−オンおよび1−オキサ−3,8−ジアザスピロ(4.5)デカン−2−オン誘導体
US20090042897A1 (en) * 2007-02-01 2009-02-12 Glaxo Group Limited Chemical Compounds
JP6503008B2 (ja) * 2017-05-30 2019-04-17 高級アルコール工業株式会社 透明油性固形化粧料

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (de) * 1964-04-22
US3594306A (en) * 1967-04-03 1971-07-20 Great Canadian Oil Sands Separation cell and scavenger cell froths treatment
FR96352E (fr) * 1967-12-29 1972-06-16 Science Union & Cie Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation.
FR2036557A5 (de) * 1969-03-25 1970-12-24 Logeais Laboratoires
GB1301254A (de) * 1971-07-08 1972-12-29
US3856797A (en) * 1972-12-29 1974-12-24 Yoshitomi Pharmaceutical 8-aminoalkyl-3-oxo-1-thia-4,8-diazaspiro(4.5)decanes and analogs thereof
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1028531C (zh) 1995-05-24
HUT55783A (en) 1991-06-28
ES2062386T3 (es) 1994-12-16
YU47749B (sh) 1996-01-08
IL95322A (en) 1994-01-25
EP0412820A2 (de) 1991-02-13
EP0412820B1 (de) 1994-03-02
NO903510D0 (no) 1990-08-09
DE69006973T2 (de) 1994-06-16
ATE102204T1 (de) 1994-03-15
EP0412820A3 (en) 1991-11-27
PL164654B1 (pl) 1994-08-31
CN1049347A (zh) 1991-02-20
IS1578B (is) 1995-06-08
AU6080590A (en) 1991-02-14
KR940002828B1 (ko) 1994-04-04
CN1029403C (zh) 1995-08-02
FI903973A7 (fi) 1991-02-11
NZ234844A (en) 1992-03-26
AU621239B2 (en) 1992-03-05
JPH0377886A (ja) 1991-04-03
PL164653B1 (en) 1994-08-31
HU204054B (en) 1991-11-28
IE902883A1 (en) 1991-02-27
PL286441A1 (en) 1991-07-15
DK0412820T3 (da) 1994-03-28
DD299430A5 (de) 1992-04-16
ZA906298B (en) 1991-06-26
MY107125A (en) 1995-09-30
IL95322A0 (en) 1991-06-30
KR910004629A (ko) 1991-03-29
IS3613A7 (is) 1991-02-11
YU153990A (sh) 1992-12-21
FI903973A0 (fi) 1990-08-10
US5157038A (en) 1992-10-20
CN1049348A (zh) 1991-02-20
IE62297B1 (en) 1995-01-25
DE69006973D1 (de) 1994-04-07

Similar Documents

Publication Publication Date Title
SI1216245T1 (en) Pharmaceutically active sulfonyl hydrazide derivatives
MY107240A (en) Novel 2-oxo-3, 8-diazaspiro [4,5] decane derivatives, pharmaceuticals compositions containing them and process for preparing same.
AU623545B2 (en) Novel 2-oxo-1-oxa-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing the same
AU621239B2 (en) Novel 2-oxo-1-oxa-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing the same
AU622039B2 (en) Novel 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing the same
NO862054L (no) Fremgangsmaate for fremstilling av nye berbanderivater.
HU9302081D0 (en) Procedure for producing preparations for preventing and/or curing ulceral diseases